A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)

Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/2011
10/27/2011	US20110263567 Compounds for inhibiting semicarbazide-sensitive amine oxidase (ssao) / vascular adhesion protein-1 (vap-1) and uses thereof for treatment and prevention of diseases
10/27/2011	US20110263565 Compounds
10/27/2011	US20110263556 New Compounds
10/27/2011	US20110263555 TGR5 Modulators and Methods of Use Thereof
10/27/2011	US20110263545 Hepatoprotectant acetaminophen mutual prodrugs
10/27/2011	US20110263543 Anti inflammatory compounds
10/27/2011	US20110263541 Kinase inhibitors and their use as pharmaceutical agents
10/27/2011	US20110263539 Ship 1 modulator compounds
10/27/2011	US20110263532 Halofuginone analogs for inhibition of trna synthetases and uses thereof
10/27/2011	US20110263526 Nitric Oxide Releasing Prodrugs of Therapeutic Agents
10/27/2011	US20110263504 Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
10/27/2011	US20110263501 Growth Hormone Conjugate with Increased Stability
10/27/2011	US20110263494 Nonsteroidal compounds useful as modulators of glucocorticoid receptor ap-1 and/or nf-kappab acitivity and use thereof
10/27/2011	US20110263492 Method to generate water soluble or nonwater soluble in nanoparticulates directly in suspension of dispersion media
10/27/2011	US20110263480 Method for treating prostatitis utilizing modified pore-forming protein proaerolysin
10/27/2011	US20110263478 Sur1 inhibitors for therapy
10/27/2011	US20110263027 Adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
10/27/2011	US20110262552 Compositions Comprising Plant Extracts and Use Thereof for Treating Inflammation
10/27/2011	US20110262539 Pharmaceutical compositions
10/27/2011	US20110262531 Nanoparticulate system, process for the preparation of the same, use of the same, photoprotective composition, process for the preparation of the same, method of prevention of diseases of the skin
10/27/2011	US20110262527 Cationic lipids and methods of use
10/27/2011	US20110262506 Topical compositions containing coated active agents
10/27/2011	US20110262503 Flowable Wound Matrix and its Preparation and Use
10/27/2011	US20110262496 Therapeutic formulation for reduced drug side effects
10/27/2011	US20110262492 Catalyst and byproduct-free native chemical ligation using cyclic thioester precursors
10/27/2011	US20110262490 Polymer-agent conjugates, particles, compositions, and related methods of use
10/27/2011	US20110262485 Sting (stimulator of interferon genes), a regulator of innate immune responses
10/27/2011	US20110262466 Compositions containing thrombomodulin domains and uses thereof
10/27/2011	US20110262462 Polymorphism markers for predicting response to interleukin-6 receptor-inhibiting monoclonal antibody drug treatment
10/27/2011	US20110262461 Biological materials and uses thereof
10/27/2011	US20110262449 Method for the treatment of gout or pseudogout
10/27/2011	US20110262445 Anti-il-12/il-23 antibodies
10/27/2011	US20110262444 Form-specific antibodies for nag-1 (mic-1, gdf-15), h6d and other tgf-beta subfamily and heart disease and cancer diagnoses
10/27/2011	US20110262438 Biological materials related to cxcr7
10/27/2011	US20110262435 Il-13 binding agents
10/27/2011	US20110262432 mutated netrin 4 proteins, fragments thereof and their uses as drugs
10/27/2011	US20110262430 Novel antibodies
10/27/2011	US20110262427 Amino acid sequences that modulate the interaction between cells of the immune system
10/27/2011	US20110262419 Specifically targeted catalytic antagonists and uses thereof
10/27/2011	US20110262418 Composition and methods for relief of neuropathological pain
10/27/2011	US20110262413 Methods of reducing extravasation of inflammatory cells
10/27/2011	US20110262409 Composition comprising a combination of an elder extract and a strain of l. paracasei, l. casei, l. bulgaricus or s. thermophilus
10/27/2011	US20110262396 Combination treatments comprising protease binding proteins for inflammatory disorders
10/27/2011	US20110262395 Sensory receptors for chronic fatigue and pain and uses thereof
10/27/2011	US20110262392 Medium derived from stem cells as a pharmaceutical composition
10/27/2011	US20110262390 Composition and method for treating inflammatory disorders
10/27/2011	US20110262388 Novel inhibitors
10/27/2011	US20110262379 Maleamic Acid Polymer Derivatives and Their Bioconjugates
10/27/2011	US20110262373 Personalised pharmaceutical composition containing retinoic acid, for anti-aging of the skin
10/27/2011	US20110262368 C21 thioethers as glucocorticoid receptor agonists
10/27/2011	US20110262360 Compositions Comprising Enzyme-Cleavable Phenol-Modified Opioid Prodrugs and Inhibitors Thereof
10/27/2011	US20110262359 Compositions comprising enzyme-cleavable prodrugs of active agents and inhibitors thereof
10/27/2011	CA2794127A1 Combination of a serotonin and norepinephrine reuptake inhibitor and an opioid agonist for the treatment of pain
10/26/2011	EP2380890A1 New 7,8-dihydro-1,6-naphthyridin-5(6h)-one-derivatives as PDE4 inhibitors
10/26/2011	EP2380877A1 Pyridine-3-carboxyamide derivative
10/26/2011	EP2380584A1 Immunostimulatory method
10/26/2011	EP2380578A1 Bioactive agent, pharmaceutical product, cosmetic product, freshness keeping agent, and plant and animal growth promoting agent
10/26/2011	EP2380575A1 Eslicarbazepine acetate and methods of use
10/26/2011	EP2380573A1 Eslicarbazepine acetate and methods of use
10/26/2011	EP2380023A2 Oxidized cardiolipin as a novel pro-inflammatory factor
10/26/2011	EP2379562A1 Bicyclic pyranone derivatives as nicotinic acid receptor agonists
10/26/2011	EP2379559A2 Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders
10/26/2011	EP2379538A2 Heterocyclic compounds as phosphodiesterase inhibitors
10/26/2011	EP2379535A1 7-phenoxychroman carboxylic acid derivatives
10/26/2011	EP2379527A1 Pyrimidin- 2 -ylamino derivatives and their use to treat inflammation
10/26/2011	EP2379525A1 Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd
10/26/2011	EP2379523A1 4, 6-disubstituted 2-amino-pyrimidines as histamine h4 receptor modulators
10/26/2011	EP2379518A1 Thiadiazole-substituted arylamides
10/26/2011	EP2379499A1 New salts
10/26/2011	EP2379498A1 New polymorphic form of 1- (4- { l- ý (e) -4-cyclohexyl--3-trifluoromethyl-benzyloxyimino¨-ethyl) -2-ethyl-benzy l) -azetidine-3-carboxylic
10/26/2011	EP2379175A1 A process for preparation of hexadecyl cis-9-tetradecenoate and hexadecyl cis-10-tetradecenoate
10/26/2011	EP2252278B1 Beta-2 adrenergic agonists for use in the treatment of chronic neuropathic allodynia
10/26/2011	EP1864994B1 Par-2 agonist
10/26/2011	EP1425010B1 Substituted indoles and their use as integrin antagonists
10/26/2011	CN102227429A 3-aminocyclopentanecarboxamides as chemokine receptor modulators
10/26/2011	CN102227425A Azaindazole compounds as ccr1 receptor antagonists
10/26/2011	CN102227409A Pyridine-3-carboxyamide derivative
10/26/2011	CN102226791A Method for determining dehydroandrographolide content in Ganmaoqing capsule by high performance liquid chromatography
10/26/2011	CN102225969A Polysaccharide from Eucommia ulmoides leaves with anti-complement activity, method of extracting, separating and purifying the same
10/26/2011	CN102225923A Method for preparing dihydromyricetin from Ampelopsis grossedentata
10/26/2011	CN102225913A Rheinic acid derivatives and treatment application thereof
10/26/2011	CN102225896A Ether derivatives of rhein and their therapeutic use
10/26/2011	CN102225205A Tripterine nano structure lipid carrier and preparation method and application thereof
10/26/2011	CN102225200A Methods and compositions for modulating TWEAK and FN14 activity
10/26/2011	CN102225194A Use of Bv8 and/or EG-VEGF to promote hematopoiesis
10/26/2011	CN102225189A Preparation method of baste for eliminating bruise
10/26/2011	CN102225178A Fructus galangae extract and medicinal application thereof
10/26/2011	CN102225157A Plaster for relieving pain, stopping haemorrhage and diminishing swelling
10/26/2011	CN102225130A Traditional Chinese medicine compound for treating rheumatoid arthritis and preparation method thereof
10/26/2011	CN102225125A Externally applied traditional Chinese medicine composite for treating joint pain caused by rheumatoid arthritis and preparation method thereof
10/26/2011	CN102225115A Chinese patent medicine oral pill for treating rheumatic arthralgia
10/26/2011	CN102225108A Medicinal liquor for treating lumbago and protrusion of lumbar vertebral disc
10/26/2011	CN102225102A Medicinal liquor for treating rheumatoid arthritis
10/26/2011	CN102225097A Application of extract of Rheum emodi Wall. in preparing anti-fibrosis drug
10/26/2011	CN102225096A Rumex acetosa linn cataplasm and preparation method thereof
10/26/2011	CN102225080A Method for extracting flavonoid compounds from passion fruit leaves by ethanol-microwave soaking leaching process
10/26/2011	CN102225066A Application of ectoine and its derivative in preparation of drug for treating pancreatitis
10/26/2011	CN102225065A Parcetamol pseudoephedrine hydrochloride and dextromethorphan hydrochloride capsule and preparation method thereof
10/26/2011	CN102225048A Curcumin compound injection and intravenous injection preparation thereof
10/26/2011	CN102225046A Transdermal drug delivery formulation

1 ... 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 ... 1272